Catalog: | C-EL-1752T |
Product Type: | Test kit |
Size: | 96 tests |
Principle: | Solid Phase Sandwich ELISA |
Conjugation: | HRP |
Species: | Human |
Detection range: | 101.56-6500 pg/mL |
Sensitivity: | 33.18 pg/mL |
Specificity: | Recognizes both recombinant and natural Human c-MET |
Interference: | Preparations of the factors listed below at 50 ng/mL in a mid-range recombinant human HGFR control were assayed for interference. No significant interference was observed. |
Sample type: | Serum,Plasma |
Test type: | Quantitative |
Analysis mode: | ELISA |
Shipping: | This ELISA Kit is shipped at ambient temperature. |
Storage: | 2-8℃ |
Full name: | MET proto-oncogene, receptor tyrosine kinase |
Application: | Cancer Drug Targets; Receptor Tyrosine Kinases (RTKs) |
This c-MET ELISA Kit, Human is an enzyme-linked immunosorbent assay for the quantitative measurement of Human c-MET protein in Serum,Plasma . It contains recombinant Human c-MET, and antibodies raised against the recombinant protein. This ELISA kit is complete and ready-to-use.Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR protein is produced as a single-chain precursor, and HGF is the only known ligand. Normal HGF/HGFR signaling is essential for embryonic development, tissue repair, or wound healing, whereas aberrantly active HGFR has been strongly implicated in tumorigenesis, particularly in the development of invasive and metastatic phenotypes. HGFR protein is a multifaceted regulator of growth, motility, and invasion, and is normally expressed by cells of epithelial origin. Preclinical studies suggest that targeting aberrant HGFR signaling could be an attractive therapy in cancer.
Copyright © 2024 Creative Biogene. All rights reserved.